National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Clinical Trial Results

Summaries of Newsworthy Clinical Trial Results

< Back to Main

Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Browse by Cancer Type
Breast Cancer

Lung Cancer

Prostate Cancer

More Results
Search Trial Results

Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
Related Pages
Myeloproliferative Disorders Home Page
NCI's gateway for information about myeloproliferative disorders.

Search for Clinical Trials
NCI's PDQ® registry of cancer clinical trials.
Myeloproliferative Disorders Trial Results

1.  Low-Dose Cytarabine Improves Survival of Older Patients with Leukemia
(Posted: 03/27/2007) - Low doses of the chemotherapy drug cytarabine increased overall survival in patients with acute myeloid leukemia who were not healthy enough to receive the standard treatment of high-dose, intensive chemotherapy, according to the March 15, 2007, issue of the journal Cancer.

2.  Lenalidomide Reduces Need for Blood Transfusions in Myelodysplastic Syndrome
(Posted: 05/15/2005) - Lenalidomide (Revlimid™) reduced the need for blood transfusions in some patients with myelodysplastic syndrome (MDS), according to findings presented at the 2005 meeting of the American Society of Clinical Oncology.

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health